Actuate Therapeutics, Inc. (ACTU) stock
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.02 (-6.12%)
Close on Nov 17, 2026Market cap $6.04MP/E –Yield –
Actuate Therapeutics cash
Cash and short-term investments held at the end of each period.
Actuate Therapeutics's cash was $2.10M at Sep 30, 2026. For fiscal 2025 it was $13.16M, up 52.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.16M | +52.3% |
| FY2024 | Dec 31, 2024 | $8.64M | +192.1% |
| FY2023 | Dec 31, 2023 | $2.96M | -85.5% |
| FY2022 | Dec 31, 2022 | $20.45M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.10M | -87.6% |
| Q2 FY2026 | Jun 30, 2026 | $4.43M | -31.8% |
| Q1 FY2026 | Mar 31, 2026 | $8.13M | +109.1% |
| Q4 FY2025 | Dec 31, 2025 | $13.16M | +52.3% |
| Q3 FY2025 | Sep 30, 2025 | $16.92M | +25.2% |
| Q2 FY2025 | Jun 30, 2025 | $6.49M | +1746.0% |
| Q1 FY2025 | Mar 31, 2025 | $3.89M | +88.0% |
| Q4 FY2024 | Dec 31, 2024 | $8.64M | +192.1% |
| Q3 FY2024 | Sep 30, 2024 | $13.52M | +59.7% |
| Q2 FY2024 | Jun 30, 2024 | $351.71K | -97.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.07M | -89.9% |
| Q4 FY2023 | Dec 31, 2023 | $2.96M | – |
| Q3 FY2023 | Sep 30, 2023 | $8.47M | – |
| Q2 FY2023 | Jun 30, 2023 | $14.11M | – |
| Q4 FY2022 | Dec 31, 2022 | $20.45M | – |
See a number that looks wrong?